Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Otter

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Leukemia Research|January 1, 1988
L1210 leukemia hybrids isolated after fusion of alkylating agent-resistant sublinesF A Schmid, G M Otter, I Hirano
Clinical and Experimental Dermatology|December 23, 1998
Axillary acne agminata (lupus miliaris disseminatus faciei)A J Bedlow, M Otter, R A Marsden
Cancer Research|March 1, 1980
Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustardF A Schmid, G M Otter, C C Stock
The Journal of Biological Chemistry|July 25, 1991
Binding of tissue-type plasminogen activator by the mannose receptorM Otter, M M Barrett-Bergshoeff, D C Rijken
Cancer Research|January 1, 1985
Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agentsF A Schmid, G M Otter, B M Mehta
Cryobiology|June 1, 1981
Cryofragility and other membrane characteristics of solid mouse tumorsF A Schmid, G M Otter, D J Hutchison
Cancer Chemotherapy and Pharmacology|January 1, 1996
Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitroT C Chou, G M Otter, F M Sirotnak
Thrombosis and Haemostasis|September 29, 1989
Binding and degradation of tissue-type plasminogen activator by the human hepatoma cell line Hep G2M Otter, T J Van Berkel, D C Rijken
British Medical Journal|May 19, 1979
Steam sterilisation of sandpits infected with toxocara eggsF van Knapen, J H Franchimont, G M Otter
Cancer Research|September 1, 1986
Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 linesF A Schmid, G M Otter, C F Chen
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Leukemia Research|January 1, 1988
L1210 leukemia hybrids isolated after fusion of alkylating agent-resistant sublinesF A Schmid, G M Otter, I Hirano
Clinical and Experimental Dermatology|December 23, 1998
Axillary acne agminata (lupus miliaris disseminatus faciei)A J Bedlow, M Otter, R A Marsden
Cancer Research|March 1, 1980
Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustardF A Schmid, G M Otter, C C Stock
The Journal of Biological Chemistry|July 25, 1991
Binding of tissue-type plasminogen activator by the mannose receptorM Otter, M M Barrett-Bergshoeff, D C Rijken
Cancer Research|January 1, 1985
Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agentsF A Schmid, G M Otter, B M Mehta
Cryobiology|June 1, 1981
Cryofragility and other membrane characteristics of solid mouse tumorsF A Schmid, G M Otter, D J Hutchison
Cancer Chemotherapy and Pharmacology|January 1, 1996
Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitroT C Chou, G M Otter, F M Sirotnak
Thrombosis and Haemostasis|September 29, 1989
Binding and degradation of tissue-type plasminogen activator by the human hepatoma cell line Hep G2M Otter, T J Van Berkel, D C Rijken
British Medical Journal|May 19, 1979
Steam sterilisation of sandpits infected with toxocara eggsF van Knapen, J H Franchimont, G M Otter
Cancer Research|September 1, 1986
Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 linesF A Schmid, G M Otter, C F Chen
Pageof 9